Search Results for: Depression

May 24, 2019May 24, 2019

Drug treatment strategies for depression in Parkinson disease.

Publication date: May 23, 2019 Introduction: Depression is a common non-motor symptom in Parkinson disease (PD), occurring in approximately 20% of patients with PD. While depression can occur anytime in ... Read more

May 24, 2019May 24, 2019

Modifiable factors associated with depression and anxiety in multiple sclerosis.

Multiple Sclerosis Literature

Publication date: May 23, 2019 Modifiable lifestyle factors are implicated in multiple sclerosis (MS) symptoms but their role in mood is unclear. This study aims to investigate associations between lifestyle ... Read more

$Safety of Electroconvulsive Therapy in Treatment-Refractory Depression in the Setting of Multiple Sclerosis.$

May 24, 2019May 24, 2019

Safety of Electroconvulsive Therapy in Treatment-Refractory Depression in the Setting of Multiple Sclerosis.

Multiple Sclerosis Literature

Publication date: May 14, 2019 Oilgmueller, J., Sharma, A., Egbert, M., and , Tran. Safety of Electroconvulsive Therapy in Treatment-Refractory Depression in the Setting of Multiple Sclerosis. 18071. 2019 J ... Read more

May 20, 2019May 20, 2019

Opioid-Induced Sedation and Respiratory Depression: Are Sedation Scales Enough to Prevent Adverse Drug Events Postoperatively?

Opioids Literature

Publication date: May 15, 2019 Nurses who care for hospitalized patients are responsible for ensuring adequate pain management is provided in a safe manner. The clinical challenge is balancing the ... Read more

May 17, 2019May 17, 2019

Implementing a Clinical Practice Guideline on Opioid-Induced Advancing Sedation and Respiratory Depression.

Opioids Literature

Publication date: May 14, 2019 Opioid-induced respiratory depression (OIRD) is a serious adverse reaction associated with opioid administration. The purpose of this quality improvement study was to evaluate the impact ... Read more

May 15, 2019May 15, 2019

Longitudinal Association Between Depression and Inflammatory Markers: Results From the Netherlands Study of Depression and Anxiety.

Precision Medicine Literature

Publication date: May 15, 2019 While cross-sectional associations of inflammatory markers interleukin-6 (IL-6) and C-reactive protein with major depressive disorder are well established, evidence for longitudinal associations mostly comes from ... Read more

May 7, 2019May 7, 2019

Anxiety, Depression Associated With Levodopa-Responsive Freezing of Gait in Parkinson Disease

Parkinson's Disease News

Publication date: May 07, 2019 PHILADELPHIA – Depression and anxiety are associated with levodopa-responsive freezing of gait (FOG) in patients with Parkinson disease (PD), but not with levodopa-unresponsive FOG, according ... Read more

May 1, 2019May 1, 2019

Associations of demographic and clinical factors with depression over 2.5-years in an international prospective cohort of people living with MS.

Multiple Sclerosis Literature

Publication date: May 01, 2019 Depression is highly prevalent among people with MS, and determinants thereof would be useful. We examined the relationship of demographic and clinical factors with positive ... Read more

May 1, 2019May 1, 2019

Associations of demographic and clinical factors with depression over 2.5-years in an international prospective cohort of people living with MS.

Multiple Sclerosis Literature

May 1, 2019May 1, 2019

Polymorphism in the serotonin transporter gene polymorphisms ( 5-HTTLPR) modifies the association between significant life events and depression in people with multiple sclerosis.

Multiple Sclerosis Literature

Publication date: May 01, 2019 In the general population, variation in the serotonin-transporter-linked polymorphic region ( 5-HTTLPR) has been shown to modify the association between stressful events and depression/anxiety. This ... Read more